Zofia Rogóż

3.6k total citations
162 papers, 3.1k citations indexed

About

Zofia Rogóż is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Zofia Rogóż has authored 162 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Cellular and Molecular Neuroscience, 60 papers in Molecular Biology and 51 papers in Pharmacology. Recurrent topics in Zofia Rogóż's work include Neurotransmitter Receptor Influence on Behavior (74 papers), Neuroscience and Neuropharmacology Research (61 papers) and Treatment of Major Depression (51 papers). Zofia Rogóż is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (74 papers), Neuroscience and Neuropharmacology Research (61 papers) and Treatment of Major Depression (51 papers). Zofia Rogóż collaborates with scholars based in Poland, Germany and United States. Zofia Rogóż's co-authors include G Skuza, Joanna Maj, H Sowińska, Marta Dziedzicka‐Wasylewska, Jerzy Maj, Beata Legutko, Krzysztof Kołodziejczyk, Katarzyna Kamińska, Wojciech Danysz and Daniel Dlaboga and has published in prestigious journals such as Biological Psychiatry, International Journal of Molecular Sciences and Journal of Neurochemistry.

In The Last Decade

Zofia Rogóż

158 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zofia Rogóż Poland 31 1.9k 1000 751 689 529 162 3.1k
Violetta Klimek Poland 28 1.8k 1.0× 889 0.9× 444 0.6× 444 0.6× 621 1.2× 57 2.8k
Ian A. Paul United States 38 1.9k 1.0× 1.1k 1.1× 650 0.9× 823 1.2× 654 1.2× 91 4.0k
G Skuza Poland 28 1.4k 0.8× 850 0.8× 555 0.7× 422 0.6× 344 0.7× 110 2.2k
Nasser Haddjeri France 33 2.3k 1.2× 1.0k 1.0× 991 1.3× 485 0.7× 385 0.7× 92 3.4k
Paul Moser France 28 1.8k 1.0× 1.2k 1.2× 445 0.6× 420 0.6× 522 1.0× 71 3.5k
Arne Mørk Denmark 33 1.9k 1.0× 1.2k 1.2× 1.1k 1.4× 622 0.9× 574 1.1× 93 4.0k
Jerzy Vetulani Poland 31 2.2k 1.2× 1.4k 1.4× 757 1.0× 306 0.4× 510 1.0× 106 3.7k
Albert Adell Spain 40 3.0k 1.6× 1.4k 1.4× 1.1k 1.4× 640 0.9× 531 1.0× 75 4.4k
Lucien Stéru France 10 1.5k 0.8× 924 0.9× 542 0.7× 952 1.4× 905 1.7× 13 3.8k
Edmund Przegaliński Poland 36 3.0k 1.6× 1.7k 1.7× 839 1.1× 652 0.9× 553 1.0× 188 4.5k

Countries citing papers authored by Zofia Rogóż

Since Specialization
Citations

This map shows the geographic impact of Zofia Rogóż's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zofia Rogóż with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zofia Rogóż more than expected).

Fields of papers citing papers by Zofia Rogóż

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zofia Rogóż. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zofia Rogóż. The network helps show where Zofia Rogóż may publish in the future.

Co-authorship network of co-authors of Zofia Rogóż

This figure shows the co-authorship network connecting the top 25 collaborators of Zofia Rogóż. A scholar is included among the top collaborators of Zofia Rogóż based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zofia Rogóż. Zofia Rogóż is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Górny, Magdalena, Anna Bilska‐Wilkosz, Małgorzata Iciek, et al.. (2020). Alterations in the Antioxidant Enzyme Activities in the Neurodevelopmental Rat Model of Schizophrenia Induced by Glutathione Deficiency during Early Postnatal Life. Antioxidants. 9(6). 538–538. 22 indexed citations
4.
Rogóż, Zofia, Agnieszka Wąsik, & Elżbieta Lorenc‐Koci. (2018). Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice. Pharmacological Reports. 70(4). 623–630. 10 indexed citations
5.
Rogóż, Zofia, Katarzyna Kamińska, Patrycja Pańczyszyn-Trzewik, & Magdalena Sowa-Kućma. (2017). Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats. Pharmacological Reports. 69(5). 885–893. 16 indexed citations
6.
Kamińska, Katarzyna, Krystyna Gołembiowska, & Zofia Rogóż. (2014). The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex. Pharmacological Reports. 66(6). 984–990. 6 indexed citations
7.
8.
Rogóż, Zofia & G Skuza. (2011). Anxiolytic-like effects of olanzapine, risperidone and fluoxetine in the elevated plus-maze test in rats. Pharmacological Reports. 63(6). 1547–1552. 42 indexed citations
9.
Rogóż, Zofia. (2009). Potentiation of the antidepressant-like effect of desipramine or reboxetine by metyrapone in the forced swimming test in rats. Pharmacological Reports. 61(6). 1173–1178. 14 indexed citations
10.
Skuza, G, Zofia Rogóż, Magdalena Szymańska, & Bogusława Budziszewska. (2009). Effects of selective sigma receptor ligands on glucocorticoid receptor-mediated gene transcription in LMCAT cells.. PubMed. 60(6). 889–95. 3 indexed citations
11.
Skuza, G & Zofia Rogóż. (2004). Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats.. PubMed. 55(6). 1149–52. 27 indexed citations
12.
Rogóż, Zofia, Andrzej Wróbel, Daniel Dlaboga, & Marta Dziedzicka‐Wasylewska. (2003). Effect of repeated treatment with mirtazapine on the central dopaminergic D2/D3 receptors.. PubMed. 54(4). 381–9. 8 indexed citations
13.
Dziedzicka‐Wasylewska, Marta, et al.. (2002). Effect of tianeptine and fluoxetine on the levels of Met-enkephalin and mRNA encoding proenkephalin in the rat.. PubMed. 53(1). 117–25. 19 indexed citations
14.
Maj, Joanna, Zofia Rogóż, Daniel Dlaboga, & Marta Dziedzicka‐Wasylewska. (2000). Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the α 1 -adrenergic and serotonergic 5-HT 2A systems. Journal of Neural Transmission. 107(11). 1345–1359. 32 indexed citations
15.
Maj, Joanna, Zofia Rogóż, & G Skuza. (1999). The anticataleptic effect of 7-OH-DPAT: are dopamine D 3 receptors involved?. Journal of Neural Transmission. 106(11-12). 1063–1073. 6 indexed citations
16.
Skuza, G, Zofia Rogóż, & Krystyna Gołembiowska. (1998). EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine system.. PubMed. 49(6). 489–93. 4 indexed citations
17.
Skuza, G, Zofia Rogóż, & A. Wieczorek. (1997). Neuropsychopharmacological profile of remoxipride in comparison with clozapine.. PubMed. 49(1). 5–15. 9 indexed citations
18.
Maj, Jerzy, et al.. (1996). Neuropharmacological profile of EMD 57445, a σ receptor ligand with potential antipsychotic activity. European Journal of Pharmacology. 315(3). 235–243. 23 indexed citations
19.
Maj, Joanna, Zofia Rogóż, G Skuza, & H Sowińska. (1990). Some central pharmacological effects of (+)- and (−)-oxaprotiline. Journal of Neural Transmission. 80(2). 129–143. 5 indexed citations
20.
Maj, Joanna, et al.. (1978). The influence of neuroleptics on the behavioural effect of 5-hydroxytryptophan.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(4). 431–40. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Violetta Klimek Breakdown of academic impact, for papers by Ian A. Paul Breakdown of academic impact, for papers by G Skuza Breakdown of academic impact, for papers by Nasser Haddjeri Breakdown of academic impact, for papers by Paul Moser Breakdown of academic impact, for papers by Arne Mørk Breakdown of academic impact, for papers by Jerzy Vetulani Breakdown of academic impact, for papers by Albert Adell Breakdown of academic impact, for papers by Lucien Stéru Breakdown of academic impact, for papers by Edmund Przegaliński
Rankless by CCL
2026